Colonization of nasal cavities by Staphylococcus epidermidis mitigates SARS‐CoV‐2 nucleocapsid phosphoprotein‐induced interleukin (IL)‐6 in the lung. Issue 7 (14th April 2022)
- Record Type:
- Journal Article
- Title:
- Colonization of nasal cavities by Staphylococcus epidermidis mitigates SARS‐CoV‐2 nucleocapsid phosphoprotein‐induced interleukin (IL)‐6 in the lung. Issue 7 (14th April 2022)
- Main Title:
- Colonization of nasal cavities by Staphylococcus epidermidis mitigates SARS‐CoV‐2 nucleocapsid phosphoprotein‐induced interleukin (IL)‐6 in the lung
- Authors:
- Kao, Ming‐Shan
Yang, Jen‐Ho
Balasubramaniam, Arun
Traisaeng, Supitchaya
Jackson Yang, Albert
Yang, John Jackson
Salamon, Benjamin Prethiviraj
Herr, Deron R.
Huang, Chun‐Ming - Abstract:
- Summary: Infection by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) can trigger excessive interleukin (IL)‐6 signalling, leading to a myriad of biological effects including a cytokine storm that contributes to multiple organ failure in severe coronavirus disease 2019 (COVID‐19). Using a mouse model, we demonstrated that nasal inoculation of nucleocapsid phosphoprotein (NPP) of SARS‐CoV‐2 increased IL‐6 content in bronchoalveolar lavage fluid (BALF). Nasal administration of liquid coco‐caprylate/caprate (LCC) onto Staphylococcus epidermidis ( S. epidermidis )‐colonized mice significantly attenuated NPP‐induced IL‐6. Furthermore, S. epidermidis‐ mediated LCC fermentation to generate electricity and butyric acid that promoted bacterial colonization and activated free fatty acid receptor 2 (Ffar2) respectively. Inhibition of Ffar2 impeded the effect of S. epidermidis plus LCC on the reduction of NPP‐induced IL‐6. Collectively, these results suggest that nasal S. epidermidis is part of the first line of defence in ameliorating a cytokine storm induced by airway infection of SARS‐CoV‐2. Abstract : Nasal administration of liquid coco‐caprylate/caprate (LCC) onto Staphylococcus epidermidis (S. epidermidis)‐colonized mice significantly attenuated NPP‐induced IL‐6. Inhibition of Ffar2 impeded the effect of S. epidermidis plus LCC on the reduction of NPP‐induced IL‐6. Collectively, these results suggest that nasal S. epidermidis is part of the first line of defense inSummary: Infection by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) can trigger excessive interleukin (IL)‐6 signalling, leading to a myriad of biological effects including a cytokine storm that contributes to multiple organ failure in severe coronavirus disease 2019 (COVID‐19). Using a mouse model, we demonstrated that nasal inoculation of nucleocapsid phosphoprotein (NPP) of SARS‐CoV‐2 increased IL‐6 content in bronchoalveolar lavage fluid (BALF). Nasal administration of liquid coco‐caprylate/caprate (LCC) onto Staphylococcus epidermidis ( S. epidermidis )‐colonized mice significantly attenuated NPP‐induced IL‐6. Furthermore, S. epidermidis‐ mediated LCC fermentation to generate electricity and butyric acid that promoted bacterial colonization and activated free fatty acid receptor 2 (Ffar2) respectively. Inhibition of Ffar2 impeded the effect of S. epidermidis plus LCC on the reduction of NPP‐induced IL‐6. Collectively, these results suggest that nasal S. epidermidis is part of the first line of defence in ameliorating a cytokine storm induced by airway infection of SARS‐CoV‐2. Abstract : Nasal administration of liquid coco‐caprylate/caprate (LCC) onto Staphylococcus epidermidis (S. epidermidis)‐colonized mice significantly attenuated NPP‐induced IL‐6. Inhibition of Ffar2 impeded the effect of S. epidermidis plus LCC on the reduction of NPP‐induced IL‐6. Collectively, these results suggest that nasal S. epidermidis is part of the first line of defense in ameliorating a cytokine storm induced by airway infection of SARS‐CoV‐2. … (more)
- Is Part Of:
- Microbial biotechnology. Volume 15:Issue 7(2022)
- Journal:
- Microbial biotechnology
- Issue:
- Volume 15:Issue 7(2022)
- Issue Display:
- Volume 15, Issue 7 (2022)
- Year:
- 2022
- Volume:
- 15
- Issue:
- 7
- Issue Sort Value:
- 2022-0015-0007-0000
- Page Start:
- 1984
- Page End:
- 1994
- Publication Date:
- 2022-04-14
- Subjects:
- Microbial biotechnology -- Periodicals
Biotechnology
Microbiology
660.62 - Journal URLs:
- http://ejournals.ebsco.com/direct.asp?JournalID=714890 ↗
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1751-7915 ↗
http://www.blackwellpublishing.com/mbt_enhanced/aims.asp ↗
http://www3.interscience.wiley.com/journal/118902527/home ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/1751-7915.13994 ↗
- Languages:
- English
- ISSNs:
- 1751-7915
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5756.911050
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 22969.xml